Close
Novotech
Jabsco PureFlo 21 Single Use

BioPharma

Pressure Protection & Safety in Pharmaceutical Manufacturing

Pressure Protection and Safety in Pharmaceutical Manufacturing Facilities The pharmaceutical manufacturing industry operates under some of the most stringent safety requirements of any industrial sector, with pressure protection pharma manufacturing systems serving as critical safeguards for personnel, equipment, and the...

Sterility in Biopharma with Contamination Control Technology

Ensuring Sterility in Biopharma: Technologies for Contamination Control The pursuit of sterility in biopharmaceutical manufacturing represents one of the most critical challenges facing the industry today. As biologic therapies become increasingly complex and potent, the imperative to maintain absolute contamination...

Korean Biopharma Market to Double Biopharma Exports By 2030

The South Korean government has gone on to hold the Bio Innovation Roundtable at Songdo Convensia in Incheon as per the theme K-Bio: Accelerating Innovation. The Ministry of Food and Drug Safety, the Ministry of Economy and Finance, the...

Russia, Vietnam Collaborate on Biopharma Technology Transfer

Russia and Vietnam have gone on to officially formalize a major collaboration in healthcare, with Russia going ahead with the biopharma technology transfer to Vietnam. It is well to be noted that this agreement was officially concluded at a signing...

Symeres acquiries DGr Pharma to enhance regulatory expertise and broaden its biopharma capabilities

Symeres, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announces the acquisition of DGr Pharma, a drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate IND-enabling capabilities for biopharma clients. The acquisition is...

Novartis-Argo $5.2 Licensing Deal for Heart Drugs

Argo Biopharmaceutical from China, which happens to be a clinical-stage biotechnology company that’s focused on developing next-generation siRNA therapeutics, has gone on to enter into an additional strategic partnership along with Novartis pertaining to numerous cardiovascular assets that prevail...

LOTTE BIOLOGICS Enters Contract Manufacturing Collaboration

LOTTE BIOLOGICS, on September 1, 2025, announced that it has gone on to enter into a late-stage commercial contract manufacturing collaboration along with one of the global biopharmaceutical companies from the US. It is well to be noted that this...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »